Protein Kinase C Gamma in the Lens

晶状体中的蛋白激酶 C 伽玛

基本信息

  • 批准号:
    7382335
  • 负责人:
  • 金额:
    $ 2.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

In the lens gap junction activity is decreased by activation of the lens/neural-specific PKC gamma isoform. This enzyme is activated by growth and stress factors such as IGF-1, LEDGF, and by hydrogen peroxide. Upon activation PKC gamma translocates to membranes and phosphorylates lens connexin proteins such as Cx43. This causes inhibiton of gap junctions through disassembly of gap junction plaques into caveolin-l-containing plasma membrane lipid rafts. This PKC gamma function could protect the lens from oxidative stress through disassembly of gap junctions and prevention of the passage of damaging signals to neighboring cells, a process which can occur during ischemia. Our hypothesis is that PKC gamma serves as a stress sensor in the lens. This isoform is more sensitive to oxidative and activation signals such as diacylglycerol, than other classical PKC isoforms. Thus, when present in cells it is the major PKC sensor of stress. The PKC gamma knock-out model is not able to decrease gap junctions in response to hydrogen peroxide and this model may be more sensitive to oxidative stress damage which causes cataracts. The specific aims, designed to test the role of PKC gamma as a lens stress sensor are: 1. Identify structural features of the lens PKC gamma which allow this to be a stress sensor. This will include identification of the docking protein and recognition sites which maintain this enzyme in an inactive state. 2. Determine how PKC gamma interacts with Cx43 and caveolin-1 in lipid rafts by identification of interaction sites on the proteins. 3. Determine the mechanism by which whole lens responds to hydrogen peroxide stress through activation of PKC gamma and decreased function of Cx46 and Cx50.4. Determine how the PKC gamma control of gap junctions is compromised during diabetes in the streptozotocin rat. 5. Assess the PKC gamma knock-out mouse model to determine the role of PKC gamma in the whole lens stress response. Peptides will be designed which can remove the PKC gamma from the 14-3-3 docking protein and activate PKC gamma in lens. This should cause disassembly of gap junctions and help to prevent damage from oxidative stress. These peptides could also be useful to prevent damage to retina from ischemia.
在透镜中,间隙连接活性通过透镜/神经特异性PKC γ亚型的激活而降低。 这种酶被生长和应激因子如IGF-1、LEDGF和过氧化氢激活。 激活后,PKC γ易位至膜并磷酸化透镜连接蛋白, Cx43这导致缝隙连接通过缝隙连接斑块的分解而形成, 含有小窝蛋白-L的质膜脂筏。这种PKC γ功能可以保护透镜免受 通过间隙连接的分解和防止破坏性信号的传递, 邻近的细胞,这是一个在局部缺血期间可能发生的过程。我们的假设是PKC γ作为 所述透镜中的应力传感器。这种亚型对氧化和活化信号更敏感, 二酰基甘油,而不是其他经典的PKC亚型。因此,当存在于细胞中时,它是PKC的主要传感器。 应力PKC γ基因敲除模型不能减少缝隙连接对氢的反应 过氧化物,并且该模型可能对引起白内障的氧化应激损伤更敏感。的 具体的目的,旨在测试PKC γ作为透镜应力传感器的作用是:1。识别结构 透镜PKC gamma的特征,其允许这是应力传感器。这将包括确定 对接蛋白和识别位点,其维持该酶处于失活状态。2.确定PKC如何 γ通过鉴定蛋白质上的相互作用位点与脂筏中的Cx43和小窝蛋白-1相互作用。3. 确定整个透镜通过激活 PKC γ和Cx46和Cx 50的功能降低。确定PKC γ如何控制间隙 在链脲佐菌素大鼠的糖尿病期间,连接受损。5.评估PKC γ敲除 小鼠模型,以确定PKC γ在整个透镜应激反应中的作用。肽将 设计了一种可以从14-3-3对接蛋白中去除PKC γ并激活PKC γ的方法, 透镜。这应该会导致间隙连接的分解,并有助于防止氧化应激造成的损害。 这些肽也可用于预防缺血对视网膜的损伤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOLORES Jean TAKEMOTO其他文献

DOLORES Jean TAKEMOTO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOLORES Jean TAKEMOTO', 18)}}的其他基金

Expression of Therapeutic Proteins in the Whole Lens
治疗性蛋白在整个晶状体中的表达
  • 批准号:
    7087723
  • 财政年份:
    2004
  • 资助金额:
    $ 2.7万
  • 项目类别:
Expression of Therapeutic Proteins in the Whole Lens
治疗性蛋白在整个晶状体中的表达
  • 批准号:
    6804864
  • 财政年份:
    2004
  • 资助金额:
    $ 2.7万
  • 项目类别:
Expression of Therapeutic Proteins in the Whole Lens
治疗性蛋白在整个晶状体中的表达
  • 批准号:
    6928457
  • 财政年份:
    2004
  • 资助金额:
    $ 2.7万
  • 项目类别:
Protein Kinase C Gamma in the Lens
晶状体中的蛋白激酶 C 伽玛
  • 批准号:
    7229429
  • 财政年份:
    2001
  • 资助金额:
    $ 2.7万
  • 项目类别:
Protein Kinase C Gamma in The Lens
晶状体中的蛋白激酶 C 伽玛
  • 批准号:
    6518720
  • 财政年份:
    2001
  • 资助金额:
    $ 2.7万
  • 项目类别:
Protein Kinase C Gamma in the Lens
晶状体中的蛋白激酶 C 伽玛
  • 批准号:
    7690541
  • 财政年份:
    2001
  • 资助金额:
    $ 2.7万
  • 项目类别:
Protein Kinase C Gamma in the Lens
晶状体中的蛋白激酶 C 伽玛
  • 批准号:
    6888020
  • 财政年份:
    2001
  • 资助金额:
    $ 2.7万
  • 项目类别:
PROTEIN KINASE C IN THE LENS
晶状体中的蛋白激酶 C
  • 批准号:
    7858038
  • 财政年份:
    2001
  • 资助金额:
    $ 2.7万
  • 项目类别:
Protein Kinase C Gamma in The Lens
晶状体中的蛋白激酶 C Gamma
  • 批准号:
    6635731
  • 财政年份:
    2001
  • 资助金额:
    $ 2.7万
  • 项目类别:
Protein Kinase C Gamma in the Lens
晶状体中的蛋白激酶 C 伽玛
  • 批准号:
    7060813
  • 财政年份:
    2001
  • 资助金额:
    $ 2.7万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了